Please join our experienced panel for an overview of significant reforms to the Committee on Foreign Investment in the United States (CFIUS), and how these changes could impact foreign investment in U.S. pharmaceutical, medical device and healthcare companies. Learn what these changes – effective February 13, 2020 – could mean for your business, including:
- Mandatory reviews of certain foreign investments
- Increased scrutiny of foreign investment in U.S. “critical technology” companies – including biotech – and U.S. companies that collect U.S. citizens’ data
- Implications for private equity, venture capital, joint ventures, and joint development agreements
- Predictions for increased enforcement in 2020
Thursday, February 27, 2020
12:00 P.M. – 1:30 P.M. ET
If you have questions concerning this roundtable webinar, email firstname.lastname@example.org.
King & Spalding is an accredited provider of CLE credit in California, Georgia, Illinois, New York and Texas. We can issue reciprocal credit for attorneys licensed in Connecticut, Florida, and New Jersey. We will apply for credit in Colorado, North Carolina and Virginia (subject to MCLE Board approval). For jurisdictions not listed, attendees are provided with a Universal Certificate of Attendance. New York licensed attorneys: Transitional/Appropriate for newly-admitted and experienced attorneys. Financial aid is available for qualifying lawyers. For CLE-related questions, please contact Gisel Arias, email@example.com. King & Spalding, 1180 Peachtree Street NE, Atlanta, GA 30309. CA Provider #10947.